Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Lecture contents
- Endothelin-1 (ET-1): vasoconstrictor
- Diverse biological roles of ET-1
- Endothelin receptors: ET(A) and ET(B) subtypes
- Questions about the features of ET receptors
- Thermostabilization of the ET(B) receptor
- Thermostabilized ET(B)-Y5 receptor
- ET(B) structure: ET-1-bound and ligand-free forms
- Binding of ET-1
- The C-terminal region of ET-1
- The α-helical region of ET-1
- The wide interaction surface of ET(B) with ET-1
- ET-1(8-21) is essential for ET(B) (1)
- ET-1(8-21) is essential for ET(B) (2)
- ET(1-7) modulates the interactions of ET(8-21)
- ET-1-induced conformational changes to ET(B)
- The cytoplasmic side of ET-1-bound ET(B)
- Inward movement of the extracellular part of TM6
- ET-1 induces inward movement of TM2 and TM7
- Weak allosteric modulation of Na+ ions in ET(B)
- Binding of bosentan
- Bosentan binds to the basic residues of ET(B)
- Bosentan utilizes the ET-1(19-21) binding site
- Summary 1
- Summary 2
- Acknowledgements
Topics Covered
- Background to endothelin, ET(A) and ET(B)
- Endothelin and peptide GPCR
- Vasoactive and mitogen-like peptide
- Thermostabilization of ET(B)
- Structures of ET-1-bound and bosentan-bound ET(B) receptor
- Ligand recognition and conformational changes of ET(B) for signal transduction
Links
Series:
Categories:
Talk Citation
Doi, T. (2019, August 29). Structure and activation of endothelin ETB receptor by endothelin [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 12, 2024, from https://doi.org/10.69645/TLAN2966.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Tomoko Doi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: G Protein-Coupled Receptors (GPCRs) Signaling in Health and Disease
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Tomoko Doi from Kyoto University.
In this seminar, I would like to present the
structures and activation of Endothelin,
ETB receptor by Endothelin.
0:16
In this presentation, firstly,
I will provide some brief background about the Endothelin system.
Secondly, I will describe the features of thermostabilized Endothelium receptor type B,
abbreviated as ETB, which we developed for crystallization.
Thirdly, I will present the structures of ETB in the ligand-free form,
bound to its agonist ET1, and bound to the antagonist Bosentan.
Finally, I will compare these structures to discuss how
the ETB receptor changes its conformation upon the binding of the agonist ET1.
1:00
In mammals, the Endothelin,
ET family comprises of three endogenous isoforms: ET1,
ET2, and ET3 found by Yanagisawa and colleagues.
They are each 21 amino acid residues long and they have
unique cyclic structures with two intramolecular disulfide bonds.
ET2 and ET3 have high sequence similarity to ET1, especially in residues 8-21.
ET1, the principle isoform in the human cardiovascular system,
is one of the most abundant,
potent, and long-lasting constrictors of human vessels.
Constriction is needed by ET receptors in smooth muscle cells;
whereas, ET receptors in endothelial cells limit
the constrictor response by releasing basal dilators such as nitric oxide.
These responses coordinate and thus, regulate local vascular tone.
There are two subtypes of ET receptors:
type A and type B,
abbreviated as ETA and ETB.
Both subtypes are GPCRs,
smooth muscle cells express both types,
while vascular endothelial cells express mostly ETB.
A number of studies have demonstrated that ET1 is